David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.1% |
| 2 | Technology | 16.45% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Communication Services | 9.04% |
| 5 | Healthcare | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XEC
2651
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $1.57M | ﹤0.01% |
26,400
-34,400
| -57% | -$1.84M |
|
2652
Mercury Insurance
MCY
$5.69B
| $1.56M | ﹤0.01% |
25,734
-31,082
| -55% | -$1.78M |
|
2653
CALL
Cheesecake Factory
CAKE
$5.58B
| $1.56M | ﹤0.01% |
+26,700
| New | +$1.35M |
|
|
ATVI
2654
PUT
DELISTED
Activision Blizzard
ATVI
| $1.56M | ﹤0.01% |
16,800
+4,300
| +34% | +$404K |
|
|
PDCO
2655
DELISTED
Patterson Companies, Inc.
PDCO
| $1.56M | ﹤0.01% |
48,854
+29,616
| +154% | +$946K |
|
2656
Universal Display
OLED
$3.96B
| $1.56M | ﹤0.01% |
6,587
-18,987
| -74% | -$4.39M |
|
2657
PUT
Tenet Healthcare
THC
$21.7B
| $1.56M | ﹤0.01% |
30,000
| – | – |
|
|
CBIO
2658
Crescent Biopharma
CBIO
$666M
| $1.55M | ﹤0.01% |
5,159
-617
| -11% | -$221K |
|
2659
PUT
Rio Tinto
RIO
$170B
| $1.55M | ﹤0.01% |
+20,000
| New | +$1.64M |
|
2660
CALL
Microchip Technology
MCHP
$40.9B
| $1.55M | ﹤0.01% |
20,000
-20,000
| -50% | -$1.49M |
|
|
SPAQ.U
2661
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
| $1.55M | ﹤0.01% |
+154,619
| New | +$1.6M |
|
2662
CALL
Stratasys
SSYS
$696M
| $1.55M | ﹤0.01% |
+59,700
| New | +$2.06M |
|
|
2663
PUT
Tencent Music
TME
$14.3B
| $1.54M | ﹤0.01% |
75,000
-250,000
| -77% | -$6.34M |
|
|
VNET
2664
PUT
VNET Group
VNET
$1.89B
| $1.54M | ﹤0.01% |
+47,600
| New | +$1.75M |
|
2665
PennyMac Financial
PFSI
$3.83B
| $1.54M | ﹤0.01% |
+22,970
| New | +$1.43M |
|
2666
PUT
Seagate
STX
$189B
| $1.53M | ﹤0.01% |
20,000
-40,000
| -67% | -$2.78M |
|
|
SCHW
2667
PUT
Charles Schwab
SCHW
$187B
| $1.53M | ﹤0.01% |
23,500
+1,900
| +9% | +$115K |
|
|
PRTK
2668
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.53M | ﹤0.01% |
216,653
-179,008
| -45% | -$1.29M |
|
2669
Brixmor Property Group
BRX
$8.97B
| $1.53M | ﹤0.01% |
+75,503
| New | +$1.41M |
|
2670
CALL
Ligand Pharmaceuticals
LGND
$5.68B
| $1.52M | ﹤0.01% |
+16,030
| New | +$1.52M |
|
|
KSMT
2671
DELISTED
Kismet Acquisition One Corp Ordinary Shares
KSMT
| $1.52M | ﹤0.01% |
153,964
+3,964
| +3% | +$40.1K |
|
2672
CALL
Bunge Global
BG
$21.6B
| $1.52M | ﹤0.01% |
19,200
+14,200
| +284% | +$1.06M |
|
2673
Amdocs
DOX
$6.66B
| $1.52M | ﹤0.01% |
21,679
-166,896
| -89% | -$12.6M |
|
2674
PUT
M&T Bank
MTB
$34.5B
| $1.52M | ﹤0.01% |
10,000
| – | – |
|
|
ENV
2675
DELISTED
ENVESTNET, INC.
ENV
| $1.51M | ﹤0.01% |
20,880
-34,387
| -62% | -$2.67M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $10.4B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.